Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




DrStockPick.com Stock Report! 10/29/09, CVAT, TGAL, HSP, ORCD, PLCE, PVA

Dr. Stock Pick (October 29th, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_______________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_______________________________________

Thursday October 29, 2009

DrStockPick.com Stock Report!

**************************************************************

Cavitation Technologies, Inc. (OTC Bulletin Board: CVAT) is pleased to announce a 3-for-1 forward stock split effective at the market open Thursday, October 29th. CTI is a world leader in the development of technologies that represent a quantum leap over existing processing methods for a wide variety of applications and industries. Positioned to provide licensing and sales of its technology which can be applied to virtually every industrial fluid that requires complex molecular bonding, including large-scale water purification, removing

...

Dell to Make Electronic Medical Records – Analyst Blog

Zacks Market Commentaries (September 11th, 2009) Writes:
Dell Inc. (DELL) recently said it would venture into the electronic medical records system business, which is used by doctors and hospitals. The device helps in storing medical records in a way that makes it easy to track the clinical history of patients from anywhere in the world without storing hard copies.

We believe the time is ideal for companies like Dell to enter this space as the federal government has granted around $19 billion in incentives to medical practitioners and hospitals. Electronic record-keeping software has huge prospects as most doctors currently use hard copies of medical records and the market is more or less recession proof.

Only 10% of American health care providers have adopted a full fledged electronic medical record system, so there is substantial growth potential in the segment. Dell is planning to combine its hardware with third-party software and provide services such as need

...

NEXC, ZYTC Stock-PR Pink Sheets Headlines September 10, 2009

stock-pr (September 10th, 2009) Writes:

NexCen Brands, Inc. (PINK SHEETS: NEXC) announced today September 10, 2009 the signing of a master franchise agreement with Teixeira Development Group, an Angolan company, for the expansion of the Company’s Great American Cookies(R), MaggieMoo’s(R), Marble Slab Creamery(R), Pretzelmaker(R), TAF(TM), and Shoebox New York(R) brands.

About NexCen Brands, Inc. NexCen Brands, Inc. is a strategic brand management company with a focus on franchising. It owns a portfolio of franchise brands that includes two retail franchise concepts: TAF(TM) and Shoebox New York(R), as well as five quick service restaurant (QSR) franchise concepts: Great American Cookies(R), MaggieMoo’s(R), Marble Slab Creamery(R), Pretzelmaker(R) and Pretzel Time(R). The brands are managed by NexCen Franchise Management, Inc., a subsidiary of NexCen Brands.

ZYTO Corp (Pink Sheets: ZYTC) announces an increase of 199 percent in top line revenue for the month of August, compared to the same period last year. Total revenue for August 2009 was $433,333, up from

...

Zargis Medical Corp. Begins Sale of Cardioscan Software, Addressing Cardiac Concerns

QualityStocks (August 25th, 2009) Writes:

Zargis Medical Corp., a spin-off from Siemens Corporate Research (NYSE:SI), a majority-owned subsidiary of Speedus Corp. (Nasdaq: SPDE), develops diagnostic decision support products and services for healthcare professionals. The company today announced that it has begun selling its Zargis Cardioscan heart sound analysis software, as well as 3M Health Care’s (NYSE: MMM) recently launched Bluetooth-enabled 3M Littmann Electronic Stethoscope Model 3200.

The introduction of the products into the marketplace is part of Zargis’ existing multi-year global marketing deal with 3M, which equips Zargis with extended marketing and promotional opportunities, as well as worldwide distribution rights of its products through 3M’s Littmann brand.

Zargis’ Cardioscan software provides support to physicians, analyzing and interpreting cardiac sounds, which gives them an upper hand in dealing with possible heart disease. Cardioscan is wirelessly connected to 3M’s Littmann Electronic Stethoscope Model 3200, which allows users to easily share and compare heart sounds recordings and related comments

...

Eastman Kodak Co. (EK) Signs MMR Information Systems, Inc. (MMRF.OB) as Independent Software Vendor

QualityStocks (August 21st, 2009) Writes:

Kodak, the world’s foremost imaging innovator, today signed MyMedicalRecords, Inc. (“MMR”), a subsidiary of MMR Information Systems Inc., as their independent software vendor in an agreement that will enhance how doctors provide electronic information online.

Kodak Scanners and Kodak Capture Software, both of which are state-of-the-art in their field, will work seamlessly with the MMR Pro System and Personal Health Records (PHR) products. Together, these technologies help healthcare professionals lower the cost and increase the efficiency of digitally capturing and managing information from paper-based medical files.

In February, President Barack Obama signed the American Recovery and Reinvestment Act (ARRA) of 2009 with improved digital records management as a top priority. MMR assists healthcare professionals in search of effective electronic document management solutions and streamlines the process of sharing health information between doctors and their patients. Presently, more than 500,000 users have access to MMR’s PHR product network.

Kodak’s document capture

...

Zacks Analyst Blog Highlights: Salesforce.com, Wal-Mart, Dell Inc., Google Inc. and Microsoft Corporation – Press Releases

Zacks Market Commentaries (August 7th, 2009) Writes:

For Immediate Release

Chicago, IL – August 7, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Salesforce.com (CRM), Wal-Mart (WMT), Dell Inc. (DELL), Google Inc. (GOOG) and Microsoft Corporation (MSFT).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Thursday’s Analyst Blog:

CRM Focuses on Healthcare

Healthcare provides a good business opportunity to information technology companies, a fact reinforced by Salesforce.com (CRM). The company is investing in Practice Fusion, which is involved in the business of electronic health records, health policy, health information technology and consumer medical data topics. Salesforce.com

...

CRM Focuses on Healthcare – Analyst Blog

Zacks Market Commentaries (August 6th, 2009) Writes:
Healthcare provides a good business opportunity to information technology companies, a fact reinforced by Salesforce.com (CRM). The company is investing in Practice Fusion, which is involved in the business of electronic health records, health policy, health information technology and consumer medical data topics. Salesforce.com will invest around $10.0 million for a marginal stake in the company, which will generate around $1.0 million of revenue a year for the company.   The cloud computing model introduced by Salesforce.com, uses online software solutions created by it. We believe that the advantages of the model are particularly applicable to the company’s clientele. In addition to the user-friendly interface, cloud computing typically lowers IT staff requirements. So medical practitioners and other professionals who prefer to manage the system on their own will find it particularly useful.   Under the new agreement, Practice Fusion’s EMR (electronic medical records product line) will be combined ...

PennyOmega.com Stock Report! 7/30/09, CYCC, MDRX, WEC, OMX, PTEN, HEP

Penny Omega (July 30th, 2009) Writes:

PennyOmega.com Stock Report!

PennyOmega.com Hot Stock News & Alerts!

signup3m

 

Thursday July 30, 2009

PennyOmega.com Stock Report!

**************************************************************

Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) announced today that it completed its previously announced registered direct offering through the sale of shares of its common stock and warrants for gross proceeds of $3.4 million, before deducting placement agent fees and offering expenses, in a registered direct offering with select institutional investors led by Special Situations Fund. The offer included the sale and issuance of 4.0 million units, at a purchase price of $0.85 per unit, with each unit consisting of (i) one share of the Company’s common stock, (ii) a five-year warrant to purchase 0.18 shares of common stock, at an exercise

...

Arrayit Corporation (ARYC.OB) Announces 50 Percent Increase in Worldwide Product Sales

QualityStocks (July 23rd, 2009) Writes:

Arrayit Corp., a proprietary life science company that has been the universal standard for printing and spotting microarrays since 1997, recently announced that the company’s worldwide product sales increased approximately 50 percent in the first half of 2009 to more than $3.1 million. Currently, more than 10,000 customers and 5,000 worldwide laboratories are utilizing the Arrayit advantage.

Arrayit has built a sophisticated network of 38 international life science and diagnostics distributors in 36 countries. Arrayit leads the genetic, research, pharmaceutical and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.

Arrayit products, which are some of the most sophisticated tools for research into diagnostics, allow healthcare professionals, pharmaceutical companies, government laboratories, life science companies, academic institutions, biotechnology companies and hospitals to quickly and accurately identify specific diseases, pathogens and viruses in humans, animals or plants.

Let us hear your

...

Cautious on Dendreon’s Rally – Analyst Blog

Zacks Market Commentaries (April 6th, 2009) Writes:
Shares of Dendreon Corp. (DNDN) jumped 38 percent last Friday and another 13% in early morning trading today. However, we don't see any clear rationale for the rally at this point of time. We believe investors are looking ahead to long-awaited data on the company's experimental Provenge vaccine to treat advanced prostate cancer, but we are cautious about the final results anticipated by the end of April. As a reminder, Dendreon's lead drug candidate Provenge is under phase III IMPACT confirmatory study for prostate cancer under a special protocol assessment (SPA) with the FDA. Provenge is a therapeutic vaccine.Previous two phase III studies generated mixed results. Study D9901 showed that Provenge approached, but did not meet its primary end point of showing a significant delay in time to disease progression (p=0.052, HR=1.4). However, Provenge showed a statistically significant median survival benefit (secondary endpoint) in ...

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.